Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction
- PMID: 7741708
- PMCID: PMC1136717
- DOI: 10.1042/bj3070775
Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction
Abstract
Desensitization of platelets to 5-hydroxytryptamine (5HT) (1 microM), during active removal of the agonist by the platelet 5HT-uptake system, was studied at the level of signal transduction. Desensitization to 5HT was dose-dependent and homologous. Without occupation of the 5HT2 receptor, neither an increase in cytosolic [Ca2+] (30 nM ionomycin), nor a separate or simultaneous activation of protein kinase C (by 10 microM 1-oleoyl-2-acetylglycerol), could induce desensitization to 5HT (1 microM). During the early phase of desensitization, the 5HT2 receptor was coupled to phospholipase C, whereas during the late phase of desensitization this coupling was disconnected. However, after disappearance of the agonist, the coupling in the resting platelet recovered quickly, and was nearly complete (82%) after 30 min. During this resensitization, the 5HT-inducibility of activation of phospholipase C, of the increase in cytosolic [Ca2+] and of stimulation of protein kinase C were restored in parallel. The time course for resensitization of the 5HT-induced increase in cytosolic [Ca2+] was independent of the presence of extracellular Ca2+. It is concluded that, after dissociation of 5HT from the platelet 5HT2-receptor, 5HT-induced responses rapidly resensitize. Because of its short duration and the parallelism in recovery between the different 'down-stream phospholipase C' intracellular transduction signals, it is considered that desensitization arises from a reversible change in the transduction mechanism at a step up to or including the activation of phospholipase C. Neither desensitization nor resensitization to 5HT is dependent on the presence of extracellular Ca2+.
Similar articles
-
Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.Naunyn Schmiedebergs Arch Pharmacol. 1984 Apr;325(4):337-42. doi: 10.1007/BF00504378. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6427633
-
Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.Biochim Biophys Acta. 1989 Feb 9;1010(2):258-64. doi: 10.1016/0167-4889(89)90170-5. Biochim Biophys Acta. 1989. PMID: 2492201
-
The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology.Int J Cardiol. 1987 Feb;14(2):177-88. doi: 10.1016/0167-5273(87)90007-6. Int J Cardiol. 1987. PMID: 3818134
-
Interactions between effectors linked to serotonin receptors.Ann N Y Acad Sci. 1998 Dec 15;861:111-20. doi: 10.1111/j.1749-6632.1998.tb10181.x. Ann N Y Acad Sci. 1998. PMID: 9928247 Review.
-
Impact of serotonin on tumour growth.Ann Med. 2000 Apr;32(3):187-94. doi: 10.3109/07853890008998826. Ann Med. 2000. PMID: 10821326 Review.
Cited by
-
Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets.J Psychiatry Neurosci. 2007 Jan;32(1):17-22. J Psychiatry Neurosci. 2007. PMID: 17245470 Free PMC article.
-
Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.J Thromb Haemost. 2010 Oct;8(10):2283-93. doi: 10.1111/j.1538-7836.2010.04000.x. J Thromb Haemost. 2010. PMID: 20670370 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous